We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $981M
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
AUM
$492M
AUM Growth
+$44.1M
Cap. Flow
+$69.8M
Cap. Flow %
14.18%
Top 10 Hldgs %
51.4%
Holding
683
New
43
Increased
101
Reduced
154
Closed
57
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
351
Sysco
SYY
$39.3B
$15K ﹤0.01%
195
+46
+31% +$3.71K
TNL icon
352
Travel + Leisure Co
TNL
$4.72B
$15K ﹤0.01%
252
-41
-14% -$2.6K
MRO
353
DELISTED
Marathon Oil Corporation
MRO
$15K ﹤0.01%
1,094
SIVB
354
DELISTED
SVB Financial Group
SIVB
$15K ﹤0.01%
27
BHVN
355
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$15K ﹤0.01%
152
DUK icon
356
Duke Energy
DUK
$99.7B
$14K ﹤0.01%
143
ETN icon
357
Eaton
ETN
$158B
$14K ﹤0.01%
92
TAK icon
358
Takeda Pharmaceutical
TAK
$53.9B
$14K ﹤0.01%
852
-205
-19% -$3.49K
TCOM icon
359
Trip.com Group
TCOM
$26.8B
$14K ﹤0.01%
397
+60
+18% +$2.29K
AKRO
360
DELISTED
Akero Therapeutics
AKRO
$13K ﹤0.01%
533
COLL icon
361
Collegium Pharmaceutical
COLL
$1.13B
$13K ﹤0.01%
532
DGX icon
362
Quest Diagnostics
DGX
$23.2B
$13K ﹤0.01%
101
-12
-11% -$1.57K
DT icon
363
Dynatrace
DT
$12B
$13K ﹤0.01%
+228
New +$11.9K
HCAT icon
364
Health Catalyst
HCAT
$151M
$13K ﹤0.01%
241
-39
-14% -$2.08K
LOW icon
365
Lowe's Companies
LOW
$115B
$13K ﹤0.01%
67
MCRB icon
366
Seres Therapeutics
MCRB
$51.1M
$13K ﹤0.01%
26
+2
+8% +$844
MDLZ icon
367
Mondelez International
MDLZ
$78.1B
$13K ﹤0.01%
205
-139
-40% -$8.56K
MO icon
368
Altria Group
MO
$121B
$13K ﹤0.01%
266
PAM icon
369
Pampa Energía
PAM
$4.8B
$13K ﹤0.01%
840
TNDM icon
370
Tandem Diabetes Care
TNDM
$1.16B
$13K ﹤0.01%
+130
New +$11.6K
GBT
371
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13K ﹤0.01%
366
ACB
372
Aurora Cannabis
ACB
$165M
$12K ﹤0.01%
130
ADP icon
373
Automatic Data Processing
ADP
$97.2B
$12K ﹤0.01%
62
ALL icon
374
Allstate
ALL
$64.8B
$12K ﹤0.01%
92
BBIO icon
375
BridgeBio Pharma
BBIO
$16.2B
$12K ﹤0.01%
203

Similar funds

Evolution Wealth Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Evolution Wealth Advisors held 683 positions worth $492M, up 9.8% from $448M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Evolution Wealth Advisors deployed $69.8M of net new capital in Q2 2021, opening 43 new positions and adding to 101 existing holdings. Its largest new stake was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF: 1,049,515 shares worth $21.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 4.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Invesco DB Commodity Index Tracking Fund, an estimated $8.55M trimmed.

  • Evolution Wealth Advisors's largest Q2 2021 buy was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF: 1,049,515 shares worth $21.1M.
  • Evolution Wealth Advisors added most to Rodgers Silicon Valley Acquisition Corp. Unit in Q2 2021, an estimated $58.7M increase.
  • Evolution Wealth Advisors's biggest Q2 2021 reduction was Invesco DB Commodity Index Tracking Fund, cutting an estimated $8.55M.
  • Evolution Wealth Advisors fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2021, selling an estimated $1M.
  • Evolution Wealth Advisors's ten largest holdings make up 51% of its $492M portfolio in Q2 2021.
  • Evolution Wealth Advisors opened 43 new positions and closed 57 in Q2 2021.
  • Evolution Wealth Advisors's portfolio value rose 9.8% quarter-over-quarter to $492M.

Based on Evolution Wealth Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.